Literature DB >> 2898181

Fungal transformations of antihistamines: metabolism of methapyrilene, thenyldiamine and tripelennamine to N-oxide and N-demethylated derivatives.

C E Cerniglia1, E B Hansen, K J Lambert, W A Korfmacher, D W Miller.   

Abstract

1. Strains of the fungus Cunninghamella elegans ATCC 9245 and 36112 were tested for their ability to transform the antihistamines methapyrilene (I), thenyldiamine (II) and tripelennamine (III). 2. Antihistamine metabolites were isolated by h.p.l.c., and identified by their 1H-n.m.r. and mass spectral properties. 3. All three drugs were transformed by both C. elegans strains to N-oxidized and N-demethylated derivatives. Metabolism during 96 h of incubation amounted to 85% for (I), 64% for (II), and 83% for (III). Metabolites soluble in organic solvents amounted to 62% to 86% of the total metabolism; approximately 88% to 95% of the organic-soluble metabolites were N-oxide derivatives of each antihistamine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2898181     DOI: 10.3109/00498258809041666

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  3 in total

1.  Microbiological transformation of enrofloxacin by the fungus Mucor ramannianus.

Authors:  I A Parshikov; J P Freeman; J O Lay; R D Beger; A J Williams; J B Sutherland
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

2.  Fungal biotransformation of the antihistamine azatadine by Cunninghamella elegans.

Authors:  D Zhang; E B Hansen; J Deck; T M Heinze; J B Sutherland; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1996-09       Impact factor: 4.792

3.  The screening of selected microorganisms for use as models of mammalian drug metabolism.

Authors:  D A Griffiths; D J Best; S G Jezequel
Journal:  Appl Microbiol Biotechnol       Date:  1991-06       Impact factor: 4.813

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.